Sonova Holding AG

Stafa, V8 · Medtech · Public

Hearing aids and auditory implants including cochlear implants, bone-conduction devices, and related hearing solutions

Claim this profile

Follows are private to you and power your alerts

Updated · sonovaholding.com

Sector
Medtech
Headquarters
Stafa, V8
Latest Form D
$12K, Feb 2024
Total capital
$93K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$93K
4 Form D · last Feb 2024
32 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

2021202220232024FEDERAL ↑EQUITY ↓Cumulative $93K1st Form D$34K2nd Form D$35K3rd Form D$12K4th Form D$12K
2021202220232024FEDERAL ↑EQUITY ↓Cumulative $93K4th Form D$12K

Latest events

  • Private capital raisedForm D · SEC · 4th filing$12K
  • Private capital raisedForm D · SEC · 3rd filing$12K
  • Private capital raisedForm D · SEC · 2nd filing$35K
  • Private capital raisedForm D · SEC · 1st filing$34K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Adrian F. WidmerDirectorNamed in SEC Form D filings
  • Andi E. VonlanthenExecutive OfficerNamed in SEC Form D filings
  • Arnd KaldowskiExecutive OfficerNamed in SEC Form D filings
  • Beat F. HessDirectorNamed in SEC Form D filings
  • Birgit F. ConixExecutive OfficerNamed in SEC Form D filings
  • Christophe E. FondExecutive OfficerNamed in SEC Form D filings
Show all 25 people
  • Claude DiversiExecutive OfficerNamed in SEC Form D filings
  • Claudio E. BartesaghiExecutive OfficerNamed in SEC Form D filings
  • Gregory F. BeharDirectorNamed in SEC Form D filings
  • Hartwig F. GrevenerExecutive OfficerNamed in SEC Form D filings
  • Jinlong F. WangDirectorNamed in SEC Form D filings
  • Julie F. TayDirectorNamed in SEC Form D filings
  • Katya KruglovaExecutive OfficerNamed in SEC Form D filings
  • Ludger AlthoffExecutive OfficerNamed in SEC Form D filings
  • Lukas F. BraunschweilerDirectorNamed in SEC Form D filings
  • Lynn F. Dorsey BleilDirectorNamed in SEC Form D filings
  • Martin E. GriederExecutive OfficerNamed in SEC Form D filings
  • Michael F. JocobiDirectorNamed in SEC Form D filings
  • Robert F. SpoerryDirectorNamed in SEC Form D filings
  • Robert WoolleyExecutive OfficerNamed in SEC Form D filings
  • Roland F. DiggelmannDirectorNamed in SEC Form D filings
  • Ronald F. van der VisDirectorNamed in SEC Form D filings
  • Stacy F. EnxingDirectorNamed in SEC Form D filings
  • Stacy F. Enxing SengDirectorNamed in SEC Form D filings
  • Victoria E. Carr-BrendelExecutive OfficerNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .